Given the downregulated tryptophan metabolism and the reduction of AHR ligand ILA production, we next examined the possibility that inhibition of AHR/MAPK9 impacts inflammatory response, oxidative stress, ER stress, and autophagy, which are important events during NAFLD [2]. This evidence concerns the gene MAPK9 and metabolic dysfunction-associated steatotic liver disease.